 [3] 
. Although much has been learned about these processes, the mechanisms underlying initiation, progression, metastasis and recurrence of cancer have not been fully elucidated despite decades of intensive investigations by thousands of dedicated cancer researchers. Extensive investigations have revealed, however, that cancer is a class of complicated genetic diseases [4]. Carcinogenesis is a complex, multi-step process by which a normal cell is stressed and transformed into cancer cells. This often requires concordant expression of a number of genes, including multiple genetic and epigenetic changes in oncogenes, tumour-suppressor genes, cell-cycle regulators, cell adhesion molecules, DNA repair genes and genetic instability as well as telomerase activation
. [7, 8] , although controversy exists regarding this assumption [9, 10] .
However, little is known about how a normal cell is initiated to transform into cancer cells. Previous research has revealed that a cancer consists of various types of tissue components, including phenotypically heterogeneous cancer cells, stromal cells, and vasculature. While heterogeneous cancer cells are believed to be malignant, the stromal cells and vascular cells of cancer have been considered to be derived from normal progenitors

Based on the heterogeneity of cancer cells, several models have been proposed to explain cancer development. The stochastic model claims that all cancer cells can reproduce phenotypically heterogeneous cell types in new tumours. However, this model cannot explain why cancer is highly heterogeneous. The CSC hypothesis may resolve the issue: it emphasizes that only a tiny population of cancer cells has the capability to produce phenotypically heterogeneous cells in new tumours; other cells only have limited proliferative capacity. Accordingly these cells have stem-like properties, having the capability of self-renewal and multi-potency of differentiation, and
thus are called CSCs [11] [12] [13] [14] [15] . However, this hypothesis is controversial and has been challenged by recent studies [16, 17] , which argue for a long-standing cancer model, well known as clonal evolution [8, [17] [18] [19] . The clonal evolution model claims that normal cells mutate and generate abnormal offspring that also mutate, forming a mass of genetically varied cancer cells. At least two hits of oncogenic mutation may be required [4, 20] . Practically, clonal evolution as a mechanism appears to underlie CSC development [2] .
Recently we have experimentally identified a new type of cancer cell from murine lymphoma [21] , representing an early stage of CSC development but similar to pre-cancer in clinical origin, having the potentials of both benign and malignant differentiation. Therefore we named these cells 'pCSCs' [2] . The pCSCs have the features of both normal and malignant (cancer) stem cells ( Table 1) . Regardless of their origin, multiple genetic alterations reflect that the pCSCs have evolutionarily undergone multi-step oncogenic mutations [2, 17] . The development of pCSCs appears to be regulated by a GS cell protein, called Piwil2 [2] , which might subvert gene expression including ES cell genes in TICs [2] .
The terminology of TIC and CSC has been used interchangeably [22, 23] . Since a cancer may develop from the cells with accumulated, mismatchingrepaired DNA damages or oncogenic mutations induced by cell stress or carcinogens [24, 25] 
, a TIC should denote a carcinogen-stimulated progenitor that is either abortively or fully developed into CSCs during tumourigenesis. In this review, the term TICs is used practically to denote the cells with oncogenic mutations prior to developing into pCSCs to avoid the conceptual confusion between TICs, pCSCs and CSCs. Theoretically all cells that are hit by carcinogens have the potential to develop into TICs.
Practically the cellular process of TIC → pCSC → CSC → cancer should parallel the histological process of hyperplasia/metaplasia (TIC) → pre-cancerous lesions (pCSC) → malignant lesions (CSC → cancer) [2, 3, [26] [27] [28] [29] [30] [31] [32] .
Although 
Stem cells and cancer stem cells
There are several models for cancer development. Can these models be unified by the CSC hypothesis? The answer may be 'yes'.
Properties of stem cells
Stem cells are characterized as the cells that can differentiate into multiple cell types and can maintain the multi-potency of differentiation through self-renewal. [39] [40] [41] . GS cells may be pleuripotent [41] . ATS [39, 49, 50] . Physiologically the balance between self-renewal and differentiation of stem cells is strictly regulated by the stem cell niche [49, 51] . The property of selfrenewal of stem cells is also called 'stemness', which is controlled by a number of stemness genes some of which are yet to be determined [52] [53] [54] [55] [56] [2] .
Cancer stem cell hypothesis
As introduced above, there are several models describing cancer development, such as the stochastic model and the clonal evolution model [4, 18, 20, 59] . The mainstay of these models is that they essentially involve multiple genetic alterations, thus converging to the model of clonal evolution [18] . These models claim that all cancer cells have the capability to reconstitute a new tumour [17] [14] . However, most important is that the CSC hypothesis should explain the entire process of tumour development (Fig. 2) . In the clinic, pre-cancer, an important stage of cancer development, is highly heterogeneous and reversible [3, 27, 29, 30] . [11, 31, [60] [61] [62] . However, the concept of CSCs was first experimentally documented for human acute myelogenous leukemia (AML) in 1994 [63] [12, 22, 23, 64, 65] . It [14, 67, 68] , pCSCs exist particularly within the established tumour [2] . The CSC hypothesis may explain why cancer cannot be eradicated by vigorous therapy [69] . Elucidation of molecular mechanisms underlying CSC development would provide novel therapeutic targets for cancer. [22, 60, 62, 71] [2] (Fig. 3) 
Initiation and progression of pre-cancerous stem cells
Since the CSC hypothesis was revived, CSCs have been experimentally identified in haematopoietic and solid cancers [12, 22, 64, 65, 74, 75] [4, 59, [76] [77] [78] . Among these stages, the dysplasia and early adenoma, but not later adenoma, represent reversible pre-cancerous lesions (Fig. 2) . These pre-cancerous lesions, like in other organs such as breast and cervix [27, 81] [82] . While the multi-potency of differentiation of NSCs is well programmed and accurately regulated, the differentiation programs are supposedly randomly activated in pCSCs and CSCs upon interaction with the tumourigenic niche [2, 83, 84] . [2, 66, 85] suggests that pCSCs persist in various stages of tumour development ( [2, 21] [2] .
Fig. 3 The model of cancer stem cell development. TICs that are adult stem cells or proliferating progenitors insulted by carcinogens may develop into pCSCs or die of programmed cell death during accumulation of epigenetic and genetic alterations. The fates of pCSCs are determined by environmental cues, and they either develop into CSCs or differentiate into benign tissue cells. Both pCSCs and CSCs are susceptible to differentiation-induced cell death (DICD). Piwil2 and piwil2-regulated genes (PRG) such as ES cell genes
Clonal evolutionary relationship of pre-cancerous stem cells to cancer stem cells
Isolation of pCSCs from established tumours as well as stem-like cancer cells from human tumour cell lines
and L. Chen et al., unpublished data). Interesting questions are what is the relationship between pCSCs and CSCs in an established tumour and are pCSCs distinct from CSCs? In a setting of an established tumour, pCSCs may dynamically provide precursors of CSCs, amplifying the pool of terminal cancer cells. As a result, the tumour then contains many populations with different genetic mutations
According to the CSC hypothesis ( Fig. 2) , while CSCs are supposed to inevitably reconstitute new tumours in the recipients [1] , pCSCs may not necessarily reconstitute the tumours when transferred to recipients. The outcome of the transplant depends on environmental niches [2] . Additional genetic mutations may occur when pCSCs progress to cancer [2] . We have noticed that the karyotype of pCSCs are relatively stable compared to differentiated or terminal cancer cells [2] [2] . In the murine system, pCSCs and CSCs can be discriminated based on their capacity for tumourigenesis in the animal models with different environmental cues [2] ( Table 1 ). The current human CSC xenotransplantation models do not in practice discriminate CSCs from pCSCs [12, 22, 64, 65, 74, 75] [12, 22, 64, 65, 74, 75] . Most CSCs have been characterized using the putative markers that identify normal ATS cells [22, 23, 63, 64, 88] [85, 90, 91] . Usually the SP has stem cell activity [66, 85, 90] [110] , Fzd5 [111] , ␤-catenin [112] , Smo [113] , c-Myc [114] , Flt3 [115] , Bcl-2 [116] and stat-3 [52] . Importantly pCSCs also expressed ES cell-and GS cell-related genes, including POUF1/Oct-4 [117] , TDGF1/Cripto [118] , Zfp42/REX1 [119] , SOX2 [120] and piwil2 [121] , which are not expressed in normal ATS cells [2] [123] [124] [125] , although this is controversial [126] . Tumour angiogenesis denotes a process of the formation of tumour vasculature from pre-existing blood vessels or circulating endothelial progenitor cells (EPCs), which is mainly mediated by the VEGF family produced by host or tumour cells [127, 128] [2] . This finding prompted us to explore whether pCSCs contribute to tumour vasculature. In support of the hypothesis, we have observed that pCSCs not only produce VEGF and angiogenic factors but also serve as TVPCs (Fig. 2) . [193] 
. In contrast, tumour vasculogenesis is a process of the formation of new blood vessels from tumour-derived TVPCs, which can be mediated by the same factors for angiogenesis. The discovery of pCSCs implicates that tumour stromal cells and vasculature may be derived from the same precursors of cancer cells. pCSCs have been shown to develop into hepatoid cells and endothelial-like cells in regenerative tissues
In the pCSC-derived tumours, tumour neovascularization seems mainly mediated by the mechanism of tumour vasculogenesis rather than by angiogenesis, suggesting that tumour vasculogenesis is crucial for tumour growth
Does the frequency of pre-cancerous and cancer stem cells in tumours determine the growth rate of cancer?
The frequency of pCSCs and CSCs in tumours may be highly variable; for example, the frequency of CSCs in human colon cancer varies 10 times or more between individuals [23]. It is not clear whether the variation is associated with the cancer prognosis. However, in breast cancer, CD44
+ CSCs seem to correlate with poor clinical outcome [17] , suggesting that the frequency of CSCs might be a predictor of cancer prognosis. In contrast to the putative CSCs in solid tumours [12, 23] , the frequency of LSCs is extremely low in the human AML, approximately 0.1-1 per million AML blasts [63, 75] [129] [2] .
. The cell capable of initiating human AML in non-obese diabetic mice with severe combined immunodeficiency disease (NOD/Scid) mice possesses the differentiative and proliferative capacities and the potential for self-renewal expected of an LSC [75]. By tracking individual human LSCs in NOD/Scid mice serially transplanted with AML cells, LSCs were found not to be functionally homogeneous but, like the normal HSC compartment, comprise distinct hierarchically arranged LSC classes
Understanding of the mechanisms underlying pCSC and CSC migration and colonization is important for developing strategies to prevent cancer metastasis. Recently it has been demonstrated that some tissue stem cells such as neural stem cells can selectively migrate to the site of cancer -the phenomenon of moving towards the diseased area is called pathotropism [133]. This implicates an important biological mechanism underlying cancer metastasis. Do pCSCs and CSCs have the ability of pathotropism? It is worthwhile to clarify the issue. For example, is the site of inflammation a destination of pCSC and CSC migration? If so, what is the driving force for the migration? As discussed above, pCSCs, CSCs, and various types of differentiated cancer cells may coexist in established tumours. It is likely that pCSCs and CSCs are the origin of metastatic cancer, which not only provide the precursors of differentiated cancer cells, but also supply the need for the build-up of cancer stromal components such as tumour neovasculature. Better characterization of the capability and destination of pCSC and CSC migration as well as the niches required for their expansion and differentiation will facilitate the understanding of the mechanisms underlying cancer metastasis.
Clonal evolution underlies the development of TICs → → pCSCs → → CSCs
A critical question is how the oncogenic program is initiated or activated in TICs? Epigenetic alterations induced by carcinogens in TICs may be an initial step of carcinogenesis. Is clonal evolution contradictory to the CSC hypothesis? The answer may be 'no'. In contrast, increasing evidence indicates that clonal evolution is a feature of TICs → pCSCs → CSCs, and can be integrated into the context of the CSC hypothesis.
Tumour initiation (TIC → → pCSC): epigenetic alterations precede genetic mutations
As discussed above, the CSC hypothesis holds that CSCs can give rise to a tumour in tumourigenic niches (Fig. 2) [4] [5] [6] 134] .
Regardless of the origin of CSCs, the initial step of carcinogenesis may start from epigenetic changes of the affected cells or TICs [135] [136] . The phenomenon, which is called 'field or geographical effect', was also observed in colon cancer [137, 138] (Fig. 2) 
. As discussed earlier, CIN/aneuploidy is likely found in the progenies of CSCs. This model might lead us to elucidate the mechanisms underlying CSC initiation.
Tumour progression (pCSC → → CSC): additional dynamic genetic alterations
In tumourigenic environments, pCSCs undergo phenotypic, morphologic and genomic changes while forming tumours [2] . (14) in 90 .6% (29/32) 
of the cells, while the other three cells had the dup(14) and a third copy of the del(15), thus showing karyotypic evolution in both clones of this line compared with the parental pCSC line [2]. These changes occurred dynamically in vivo within only a few weeks of transfer, whereas no significant change was observed for all clones of pCSCs during >3 years of in vitro maintenance (our unpublished observations). These observations indicate that additional genetic alterations were required when pCSCs progress to cancer, although the precise genes affected by the evolution need to be explored further.
The dynamic genomic alterations of pCSCs progressing to cancer reflect a clonal evolutionary mechanism underlying CSC development. Clonal evolution has been considered as the mechanism underlying tumour development including metastasis before the CSC hypothesis was revived [17, 19] [193] . [36] . [153] . Since the molecules governing the self-renewal of ATS cells were also identified in pCSCs and CSCs [2, 60, 154] , it is likely that pCSCs and CSCs use the same molecular pathways as ATS cells to maintain their capability of self-renewal [60, 154] . However, ectopic expression of ES and GS cell genes is unique for pCSCs and CSCs. Although the piwi protein is required for self-renewal of stem cells in various organisms [155] , piwil2 was not required for the self-renewal of adult HSCs, because the number and repopulation activity of HSCs from the BM of piwil2-disrupted mice was not affected [121] . Thus, the role of piwil2 in the self-renewal of pCSCs and CSCs remains elusive. [2] or cancer cells [35] [36] [37] . In contrast, the GS cell gene or protein of piwil2 has been stably detected in pCSCs [2] and pre-cancerous lesions [193] , suggesting that piwil2 may be unique for pCSC and CSC development. [121, 156] , is a member of the PIWI/Argonaute gene family [157] . The genes of the piwi family are defined by highly conserved PAZ (Piwi/Argonaute/Zwille) and Piwi (P-element induced wimpy testis) domains and play important roles in stem cell self-renewal [155] , gametogenesis [121] , small RNA-mediated gene silencing [158] , and translational regulation in various organisms [158] .
ES and GS cell-related genes are usually undetectable in normal ATS cells, despite few reports implicating that ATS cells may also express ES cell-related genes
Whether the expression is due to TICs and/or pCSCs in the individuals tested is an interesting issue. CSCs, like pCSCs, expressed ES, GS and ATS cell-related genes as well. However, the expression pattern of these genes seems to be less stable compared to that observed in pCSCs. As compared to pCSCs, CSCs expressed fewer ES cell genes within an individual clone, up-regulated Smo transcripts, and down-regulated piwil2 transcripts ([2] and L. Chen et al., unpublished data). The ectopic expression of ES and GS cell genes in pCSCs and CSCs can be considered as 'atavism' of ATS/progenitor cells, which confer upon ATS cells the properties of ES cells, such as indefinite growth or immortalization.
Molecular pathways for self-renewal of pre-cancerous and cancer stem cells
Role of piwil2 in the development of pre-cancerous and cancer stem cells
piwil2 (alias mili in mouse or hili in humans), which is exclusively expressed in GS cells of testis
The PAZ domain is found only in Piwi/Argonaute proteins and Dicer. Argonaute proteins are the catalytic components of the RNA-induced silencing complex (RISC) [159, 160] , the protein complex responsible for the gene silencing via a mechanism of RNA interference (RNAi) [161] . Dicer [164] .
The piwi is a protein domain homologous to piwi proteins in Drosophila and, like the PAZ domain, is present in PIWI/Argonaute gene family proteins [157] , which bind and cleave RNA [162, 164] [164] . Piwi proteins, a subfamily of PIWI/Argonaute gene family, contain two important members, piwil1 (alias miwi in mouse or hiwi in human beings) and piwil2 [157] .
There is no evidence so far that piwi protein is a component of the RISC [165, 166] . It has been reported that piwi proteins, unlike Argonaute proteins, seem not to be associated with micro-RNA (miRNA) or siRNA [166] . However, piwi proteins do have target RNA cleavage activity, independent of Dicer [165] . Both piwil1 and piwil2 were found to bind a novel class of RNA called piwi-interacting RNA (piRNA) or repeat-associated small interfering RNAs (rasiRNAs) in mammal testis [165] [166] [167] [168] [169] . They may silence the selfish genetic elements, such as retrotransposons, in the germ line cells of testis [167] [168] [169] [170] [171] .
Dysregulated piwi protein expression appears to be associated with tumourigenesis [2, 172, 173] . Although piwil1 was up-regulated in seminomas [172] , it was not detected in pCSCs [2] . In contrast, piwil2 was stably expressed in pCSCs and pre-cancerous lesions [2, 193] (109.5 kD) , is exclusively expressed in GS cells of testis [121, 156, 157] [42, 43, [174] [175] [176] [177] [178] and probably in CSCs [35, 74] , although there have been great controversies [44, 179, 180] . Our observations suggest that the transdifferentiation may be related to subverted expression of ES cell genes in pCSCs, which confers upon pCSCs the 'pleuripotency' of differentiation, albeit incomplete [2] . Certainly, the transdifferentiation is pathologic, and may not be reproducible with normal counterpart ATS cells [179] . ES cell genes have been detected in normal and bulk cancer cells [36, 181] [8] . We would like to share our experiences with the reader (Fig. 4) [129] . It is conceivable that the CSCs isolated from human haematopoietic and solid cancers might be a mixture of pCSCs and CSCs [12, 23, 63] . Owing to the low frequency and phenotypic heterogeneity of pCSCs and CSCs in tumours, it would be difficult to phenotypically discriminate pCSCs from CSCs, or CSCs from cancer cells [17, 182] . Thus, it is necessary to establish a series of clonal cell lines for better characterization of pCSCs and CSCs at the cellular and molecular levels.
In the murine system, the potential of pCSCs and CSCs for reconstituting tumour can be tested in SCID, BMR and IC mice [2] [12] and brain CSCs in the brain [22] . However, this model does not distinguish pCSCs from CSCs. Pre-cancer appears to be distinct from cancer in engraftment after transplantation [3, 27] . In an animal model of human breast cancer [27, 29] Following establishment of immortalized cell lines, pCSCs and CSCs should be cloned and characterized through a three-step procedure (Fig. 4) Fig. 3 ). While serial transplantation is a gold standard for self-renewal activity [2, 21] , colony formation in soft agar or colony-forming cell (CFC) assays may also be used for screening of the clones for selfrenewal activity [2, 184] [2, 173, 193] , suggesting that piwil2 has the potential to be used as a common biomarker for early detection of cancer.
Potential of pre-cancerous and cancer stem cells as a target for immunoprevention
As discussed above, pCSCs and CSCs may exist in established tumours to replenish growing tumours [2, 21] 
Potential of pre-cancerous and cancer stem cells for the development of tumour vaccines
Large numbers of T-cell specific tumour antigens associated with testicular or embryonic antigens have been identified [118, [189] [190] [191] [36, 118, 181, 192] , and some of them such as SOX2 have demonstrated strong immunogenicity in patients with monoclonal gammopathy [192] . These interesting findings strongly implicate that tumour vaccines against pCSCs and CSCs might be safe and cost-effective in the prevention and treatment of cancer. 
Concluding remarks
